Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Px-Meal: Glucagon Regulation in Pancreatectomy
NCT04061473Completed
- Sponsor
- Gentofte Hospital
- Start
- Apr 2019
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of sitagliptin and empagliflozin in diabetes mellitus (DM) (6 arms), sponsored by Gentofte Hospital. Primary endpoint: Glucagon excursions measured as incremental area under the curve. Started Apr 2019; status: completed.
02
Drugs
sitagliptinempagliflozin
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on NCT04061473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04061473.